Objective: Periventricular nodular heterotopias (PNHs) are malformations of cortical development related to neuronal migration disorders, frequently associated with drug-resistant epilepsy (DRE). Stereo-electroencephalography (SEEG) is considered a very effective step of the presurgical evaluation, providing the recognition of the epileptogenic zone (EZ). At the same time, via the intracerebral electrodes it is possible to perform radiofrequency thermocoagulation (SEEG-guided RF-TC) with the aim of ablating and/or disrupting the EZ. The purpose of this study was to evaluate both the relationships between PNH and the EZ, and the efficacy of SEEG-guided RF-TC. Methods: Twenty patients with DRE related to PNHs were studied. Inclusion criteria were the following: (1) patients with epilepsy and PNHs (unilateral or bilateral, single or multiple nodules) diagnosed on brain magnetic resonance imaging (MRI); (2) SEEG recordings available as part of the presurgical investigations, with at least one intracerebral electrode inside the heterotopia; (3) complete surgical workup with SEEG-guided RF-TC and/or with traditional neurosurgery, with a follow-up of at least 12 months. Results: Complex and heterogenic epileptic networks were found in these patients. SEEG-guided RF-TC both into the nodules and/or the cortex was efficacious in the 76% of patients. Single or multiple, unilateral or bilateral PNHs are the most suitable for this procedure, whereas patients with PNHs associated with complex cortical malformations obtained excellent outcome only with traditional resective surgery. Significance: Each patient had a specific epileptogenic network, independent from the number, size, or location of nodules and from the cortical malformation associated with. SEEG-guided RF-TC appears as a new and very effective diagnostic and therapeutic approach for DRE related to PNHs.
feature is drug-resistant epilepsy (DRE). 10, 11 In these patients, surgery can therefore be an option, but defining the epileptogenic zone (EZ; the amount of the cerebral cortex to be removed to avoid seizure recurrence) is a challenge, and invasive techniques such as stereo-electroencephalography (SEEG) are needed. SEEG permits not only the identification of the seizure onset zone, but it can also reveal the relationship between the nodular heterotopia and the cortex, in terms of generation, propagation, and synchronization of interictal and ictal discharges highlighting the patient-specific epileptogenic networks.
Few studies have focused on SEEG data in patients with PNH, providing heterogenic results: ictal discharges may arise from heterotopia, simultaneously from the nodule and the overlying cortex, or from distant cortical areas without heterotopic involvement. [12] [13] [14] [15] Traditional surgery consisting of the removal of the EZ, not necessarily involving the PNHs, has not frequently had a good outcome, 14, 16 whereas other studies have shown poor outcome after a simple temporal lobe resection not inclusive of the nodular malformation. 6 Recently, less invasive neurosurgical techniques are gaining more and more consideration in epilepsy surgery, such as radiofrequency thermocoagulation (SEEG-guided RF-TC) through intracerebral electrodes and laser ablation, both consisting of treatments targeted directly to the lesion, thereby avoiding cortical resection. Few reports have shown encouraging results coming from the use of these techniques in patients with PNHs, although due to a large heterogeneity and to the very small number of described patients (case reports), it is still difficult to draw conclusions. [17] [18] [19] [20] [21] The target of this retrospective study was to evaluate the capability of SEEG investigations in defining the site and extension of the EZ in these complex cortical malformations, and the efficacy of SEEG-guided RF-TC in a consecutive series of patients with PNHs, with different clinical and neuroradiologic pictures.
Subjects/Materials and Methods

Patients
Among 5,323 patients undergoing epilepsy surgery evaluation at the "C. Munari" Epilepsy Surgery Center at the Niguarda Hospital in Milan, from November 1998 until January 2016, 102 patients were diagnosed with epilepsy related to PNHs. After a comprehensive evaluation inclusive of clinical history, neurologic examination, and video-EEG monitoring, a selection was performed on the basis of the following inclusion criteria: (1) patients of any age with epilepsy and PNHs (unilateral or bilateral, single or multiple nodules, associated or not with other MCDs) diagnosed with cerebral magnetic resonance imaging (MRI); (2) SEEG as part of the presurgical investigations, with at least one intracerebral electrode localized inside one heterotopic nodule; (3) a complete surgical workup, either with SEEGguided RF-TC, or with traditional neurosurgery, or both, with a follow-up period of at least 12 months. Twenty patients fulfilled these criteria and were included in the study (Fig. S1 ).
Neuroimaging procedures
Brain MRI (Achieva 1.5 T, Philips Healthcare) was available for each patient. The following sequences were acquired: axial and coronal turbo spin echo (TSE) T 2 -weighted; coronal axial and sagittal TSE fluid-attenuated inversion recovery (FLAIR) T 2 -weighted; and axial and coronal TSE inversion recovery (IR) T 1 -weighted. Threedimensional (3D) volume fast-field echo T 1 -weighted images were also obtained. Neuroimaging data were reviewed to precisely identify the malformations, particularly number, localization, and lateralization of the heterotopic nodules in the subependymal and or subcortical regions, and the potential association with other MCDs.
An 18-fluorodesoxyglucose-positron emission tomography (18-FDG-PET) was obtained whenever possible and superimposed on the patient-specific 3D brain MRI in order to identify potential alterations of the cerebral metabolism and to precisely localize them.
Video Stereo-EEG monitoring
A description of the intracerebral electrodes implantation methodology and safety has been detailed elsewhere. 17, [22] [23] [24] All the neurophysiologic data obtained by SEEG monitoring were reviewed with the aim of identifying interictal and ictal activity involving PNHs, the overlying cortex or distant cortical regions; seizures recorded were subdivided upon their onset from the heterotopia, the cortex or both simultaneously, and according to four different neuroradiological groups. Before proceeding to an eventual SEEGguided RF-TC interictal and ictal electrical modifications, clinical data, and results of electrical stimulations, were analyzed. The choice of the SEEG-guided RF-TC sites was based on the anatomoelectroclinical correlations.
Key Points
• SEEG revealed the intrinsic capability of PNHs in generating seizures
• SEEG-guided RF-TC was efficacious in terms of seizure freedom in the 76% of patients with PNH-related epilepsy
• SEEG-guided RF-TC can be performed in patients with bilateral PNH or with PNH adjacent to eloquent areas with excellent outcomes
• Patients with complex cortical malformations including PNH have lesser benefit from SEEG-guided RF-TC alone but reached a good outcome with SEEGguided resective surgery
Radiofrequency thermocoagulation
Radiofrequency thermocoagulation was performed at the end of the SEEG recordings, before electrode removal after the accurate analysis of SEEG data. Each thermocoagulative lesion was sited between a couple of contiguous electrode contacts. The contacts were selected for SEEG-guided RF-TC according to their involvement in seizure onset and to their location inside the nodular heterotopia. For a detailed description of the SEEG-guided RF-TC technique, see Cossu et al. 24 
Resective surgery
Traditional resective surgery was conducted with the aim of the removal of the EZ, as defined by SEEG data. Surgery was performed as the only treatment when SEEG-guided RF-TC was not available in the center. Moreover, when patients treated with SEEG-guided RF-TC showed seizure recurrence, they subsequently underwent resective surgery.
Outcome
Results of the surgical procedures were classified in terms of seizure freedom according to Engel classification. 25 Standard protocol approvals, registrations, and patient consents Each patient or their guardians gave informed consent for both SEEG and subsequent SEEG-guided RF-TC procedure. The study received the approval of the local ethical committee.
Results
Patients
Of the 5,323 patients attending an evaluation at the "C. Munari" Epilepsy Surgery Center of the Niguarda Hospital in Milan over a period of 17.2 years, 102 had epilepsy related to periventricular nodular heterotopia (1.9%). Most patients (n = 91, 89.2%) did not respond to antiepileptic drugs, whereas only 11 (10.8%) of them presented a benign course with occasional seizures. Of the 91 patients with drug-resistant epilepsy, 47 did not complete the surgical workup for the following reasons: (1) PNH or associated MCD localized in the proximity of eloquent cerebral areas, (2) associated genetic diseases (such as Aicardi syndrome or Dandy-Walker syndrome), and (3) patients' personal decision not to proceed with the surgery program. Of the 44 remaining patients with DRE who completed the surgical workup, 20 of them (10 female) fulfilled the inclusion criteria of the study and were therefore included (Fig. S1) .
Mean age at seizure onset was 18.2 years (range 1-39), and mean duration of epilepsy was 14.2 years (range 1-29). Four patients (20%) had personal antecedents such as prematurity, perinatal distress, and dystocic birth, whereas in five patients (25%), a familiar history of epilepsy was present. All patients had drug-resistant epilepsy (mean number of antiepileptic drugs: 2.8); seizure frequency ranged from daily to monthly.
MRI data
Based on Barkovich's classification (2012), 9 PNHs can be categorized as anterior, posterior, or diffuse. In our series, 70% of cases (n = 14) were posterior, 20% (n = 4) diffuse, and 10% (n = 2) were anterior PNHs. Half of the patients (n = 10) had unilateral PNHs localized in the right hemisphere, 25% of cases (n = 5) were left PNHs, and the remaining 25% (n = 5) had bilateral PNHs.
Patients were divided into four groups: (1) single unilateral heterotopic nodule (n = 6 patients); (2) unilateral heterotopia with multiple nodules (n = 5 patients); (3) bilateral multi-nodular heterotopia (n = 5 patients); and (4) complex cortical malformations: nodular heterotopia associated with other MCD (n = 4 patients) ( Fig. 1) .
PET data
Thirteen patients of 20 underwent cerebral 18-FDG PET. The results of metabolic changes inside the heterotopias were heterogeneous: in the majority of cases (n = 8, 61.5%) the heterotopic nodules appeared iso-metabolic compared to the other cortical areas, whereas in five patients (38.5%) a hypometabolism was observed in at least one of the heterotopic nodules. Differences in 18-FDG uptake were observed not only among patients but also among different nodules in the same patient (Fig. S2) . Other metabolic alterations outside the heterotopias emerged: in eight patients (61.5%) a hypometabolism of the anterior mesial temporal region was observed, while in the remaining five no alterations were found.
Iso-metabolism was also present inside the complex cortical malformations associated with PNH, such as polymicrogyria, transmantle heterotopia, schizencephaly, or dysplasia (Fig. S2) .
Stereo-EEG
In the totality of patients, interictal epileptiform activity was recorded from the electrodes placed inside the heterotopias. This peculiar activity was characterized by the complete absence of physiologic rhythms, very frequent small amplitude spikes-and wave with angular morphology, and sequences of low-voltage fast activity, appearing dissimilar from the epileptiform activity recorded in other pathologies, such as focal cortical dysplasias or other MCDs. This activity was usually asynchronous with the overlying cortex during wakefulness, and often among nodules of the same patient, but tends to become more synchronous during sleep (Fig. 2) .
A total of 64 (mean per patient: 3.4 seizures; range 1-8) spontaneous seizures were recorded and analyzed: 72% (n = 46) of seizures had a right hemisphere onset, and 28% (n = 18) arose from the left side. In the majority of cases (73%, n = 47) seizures began simultaneously in the heterotopic nodule and the functionally connected cortex (frequently the overlying cortex), in20% (n = 13) in the heterotopia, and only rarely (~7%, n = 4) from the cortex alone. In all seizures a late involvement of both nodules and cortex was observed.
Considering the four groups of patients, we observed differences in the seizure-onset zones ( Fig. 3) : in group 1, including patients with a unilateral single heterotopic nodule, seizures arose mainly simultaneously from PNH and the cortex, or from PNH only; in group 2 (unilateral multinodular heterotopia) the onset was simultaneous from PNH and cortex in three of four patients, while in the remaining one seizures began only inside the heterotopia; in group 3 (bilateral multinodular heterotopia) ictal discharges arose both simultaneously and alone in the nodules; in group 4, including patients with complex cortical malformations, seizures had a synchronous onset in the nodules and the cortex in the totality of cases.
Treatment strategy and outcome
Three patients (15%) underwent only resective neurosurgery guided by SEEG data. They all attained an excellent outcome.
Seventeen patients (85%) underwent SEEG-guided RF-TC at the end of the SEEG monitoring, targeted to the heterotopias and eventual other cortical regions involved in seizure generation (Fig. 4) : in six patients SEEG-guided RF-TC was targeted only to PNHs: five of them belonged to the first group (single nodule) and the other patient had unilateral multinodular heterotopia (group 2); in 10 patients (belonging to groups 2, 3, and 4) SEEG-guided RF-TC was directed to both heterotopias and previously selected cortical regions; and in the remaining patient SEEG-guided RF-TC was performed only in the selected cortex. The efficacy (Engel class I) of this treatment achieved the 76% of cases (n = 13) with a mean follow-up of 50 months (Table 1 ).
In the remaining four patients (15%), SEEG-guided RF-TC determined only a transient period of seizures reduction (for a maximum period of 2 months), and then seizures recurred with the same frequency and semiology as before. Traditional resective surgery was then performed in these patients, with an excellent outcome in three of four. The only patient who did not improve after surgery was a female patient (patient 19), with a single heterotopic nodule, who had atypical multifocal epileptic activity on SEEG and spasm-like seizures.
The overall follow-up after surgery or SEEG-guided RF-TC is 50 months (range 12-174 months).
Moreover, SEEG-guided RF-TC was completely safe for the patients: no side effects were reported. 
Discussion
This research focused on the electrophysiologic features of periventricular nodular heterotopias (or PNHs), obtained with SEEG recordings with at least one intracranial electrode placed inside the malformation in 20 epileptic patients, the largest group of patients with PNHs studied with this procedure in the present literature. Only a previous study included 10 patients, 14 whereas others had smaller groups or single case reports. 12, 13, 15, 24 The questions that are still debated concern the involvement of the nodular heterotopia in the generation of epileptiform activity and seizures, and also the heterotopia relationships with the overlying/underlying cortex or even with cortical regions at distance.
The totality of the heterotopic nodules explored by intracranial electrodes showed a pathognomonic interictal pathologic activity, very frequent, and mainly independent from the pathologic spiking activity recorded in the overlying or distant cortex. This activity has not been observed previously in other malformations of cortical development or other diseases. We noticed that even small heterotopias could be correlated with DRE, and that there was not a correlation between the extension of the malformation and the severity (in term of seizure frequency, number of antiepileptic drugs [AEDs], and cognitive impairment) of the clinical picture. In most of our population, seizures arise simultaneously from the nodular heterotopia and the overlying cortex (73.4%), whereas only in the heterotopias in 20.3% of cases, . Intranodular activity is displayed in pink, whereas the electrical activity of the other cortical regions is shown in black. During wakefulness, a pathognomonic activity is shown characterized by the complete absence of physiologic rhythms and very frequent small amplitude spikes-and-waves, mainly asynchronous with the surrounding cortex. During sleep, a tendency to synchronization between epileptic activity recorded from the heterotopia and from anterior mesial and basal temporal areas is observed. Moreover, sequences of small amplitude fast activity recorded in the nodules appear more frequent during sleep. (B) Example of SEEG recording during wakefulness in patient 16. Intracerebral electrode L is displayed in a 3D reconstruction on the brain MRI (above); cerebral activity of the first five contacts of electrode L during the test is displayed (below). Notable is the absence of physiologic rhythms and sequences of interictal epileptiform activity characterized by angular spikes followed by slow wave. Epilepsia ILAE and infrequently (in 6.3% of cases) only in the cortex, even distant to the nodules. Moreover, in patients with multiple nodular heterotopias, we observed that some nodules might be active and able to generate seizures, whereas others, in the same patient, were not. These types of epilepsies seem to be sustained by complex epileptic networks, which are difficult to predict even in patients with analogous neuroradiologic pictures. Heterogeneity has also been observed in 18-FDG-PET results: nodules appeared iso-metabolic (61.5% of cases) or hypo-metabolic (38.5%) with respect to the cortex, but no correlations with PET changes in PNHs and their capability of generating seizures have been observed. In 61.5% of patients studied with PET, a hypometabolism in the anteromesial temporal regions has been observed, ipsilateral to the EZ. To our knowledge, only two case reports addressing FDG-PET in PNHs are available in literature 26, 27 : in the overall three cases described, nodular heterotopias had an 18-FDG uptake similar to that of the cerebral cortex.
Despite the complexity, seizure freedom can be achieved in these patients. SEEG appears as an indispensable tool in the process, revealing the epileptic zone (EZ), and the functional relationships existing between heterotopias and the cortices. Moreover, SEEG provides a functional map of the patient-specific epileptic network, creating the possibility to disrupt and interrupt the pathological circuit.
In the 20 studied patients, 4 groups emerged differing in number, localization, and lateralization of nodules, and also in their epileptic networks. In the first three groups (single heterotopic nodules, unilateral multiple heterotopia, or bilateral heterotopia) seizures could arise either from PNH alone or from PNH and the overlying cortex simultaneously, whereas in group 4, including patients with complex cortical malformations, larger epileptic networks were identified at seizure onset, involving malformations, heterotopias, and cortex in the totality of cases; in this group heterotopia alone was never found as the sole trigger of seizures (Fig. 3) .
In patients belonging to the first three groups, SEEGguided RF-TC determined an excellent outcome, showing substantial efficacy in disrupting or stopping the pathologic networks in all cases except one (patient 19, who had atypical, previously described, features). In patients of group 4 instead, with complex cortical malformations, SEEG-guided RF-TC alone was not or only temporarily sufficient to interrupt the large epileptic network, and subsequent traditional resective surgery was necessary to achieve seizure freedom. Even in these cases, however, the temporary absence/reduction of seizures, can be interpreted as a favorable prognostic factor before surgery. Overall, radiofrequency thermocoagulation proved to be efficacious in 76% of patients with epilepsy related to periventricular nodular heterotopia, standing as the most successful treatment for these syndromes. In two patients AEDs were discontinued, and seven patients reduced the pharmacologic treatment to only one drug. The remaining patients are seizure-free and a reduction of the drug doses has already been started (Table 1) .
We also evaluated seizures outcomes of patients with PNH who previously underwent SEEG without RF-TC (before 2008), being that this technique not available at that time. In this group (n = 19 patients) a good outcome was obtained in 63.2% of the cases. This good result seems difficult to compare to the ones of the present study, for several reasons: patients were investigated in different periods and with different facilities. However, we believe that even if a limit of the present study is that a direct comparison between two therapeutic options (i.e., SEEG-guided RF-TC vs. traditional resective surgery) was not performed, SEEGguided RF-TC is a less invasive and safer procedure, 28 and very effective. This means that it would be unethical, at present, not to recommend SEEG-guided RF-TC in patients at the end of the SEEG workup.
Another finding to be highlighted, is the excellent outcome obtained with SEEG-guided RF-TC in patients with bilateral PNHs. The presence of bilateral lesions has traditionally been considered a contraindication for epilepsy surgery, and, even when electroclinical data pointed only to one side, and patients were operated, poor outcome was generally achieved. 6 In our cases, SEEG documented interictal activity from the heterotopias in both hemispheres, and even though one side was usually predominant, seizures could independently origin from both sides of the brain. Through a bilateral SEEG implantation that included always the nodules, their activity was recorded, and through bilateral SEEG-guided RF-TC it was possible to interrupt the two pathologic nodular and cortical networks localized on each side of the brain.
In conclusion, SEEG represents the best way for exploring epileptogenic networks involved in PNHs and to identify the EZ. At the same time, SEEG-guided thermocoagulation seems to be the ideal tool for interrupting these epileptic networks, allowing access to both nodules and the epileptogenic cortex. SEEG-guided RF-TC represented a very successful and safe treatment in the majority of patients. Single or multiple unilateral or bilateral PNHs are the types of malformations more suitable for this procedure, whereas PNHs associated to complex cortical malformations obtained excellent outcome with traditional resective surgery. A new diagnostic and therapeutic approach for DRE related to PNHs is therefore recommended.
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